Status:
RECRUITING
AI-Assisted Chemotherapy Side Effect Management
Lead Sponsor:
Incheon St.Mary's Hospital
Conditions:
Breast Cancer
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This two-stage adaptive randomized controlled trial evaluates the feasibility and preliminary efficacy of large language model (LLM)-assisted intervention for managing chemotherapy side effects in pat...
Detailed Description
Chemotherapy-induced side effects affect patient quality of life and treatment outcomes. Studies indicate 86% of patients receiving chemotherapy experience at least one side effect, with 30% reporting...
Eligibility Criteria
Inclusion
- Adult patients (≥ 18 years old) diagnosed with histologically confirmed solid malignancies (breast cancer, colorectal cancer)
- Patients scheduled to receive at least 3 months of systemic chemotherapy
- ECOG performance status 0-2
Exclusion
- Severe psychiatric disorders
- Cognitive impairment affecting ability to report symptoms
- Presence of cancer-related symptoms prior to chemotherapy initiation
- Concurrent participation in trials evaluating other symptom management interventions Inability to provide informed consent Life expectancy less than 6 months
Key Trial Info
Start Date :
November 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2026
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT07198581
Start Date
November 12 2025
End Date
October 31 2026
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea
Incheon, South Korea, 21431